Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Sofosbuvir Impurity 96 is a specified impurity associated with Sofosbuvir, an antiviral medication targeting the hepatitis C virus by inhibiting the NS5B polymerase. This compound serves as a critical reference standard in the analysis of Sofosbuvir formulations, ensuring quality control and compliance with pharmaceutical regulations. Its characterization is essential for laboratories conducting stability studies and impurity profiling in drug development processes. -
Drug Impurity
Montelukast impurity 4 is a chemical impurity associated with Montelukast, a leukotriene receptor antagonist used primarily in the treatment of asthma and allergic rhinitis. This impurity may be crucial for pharmaceutical quality control and regulatory compliance studies, investigating the safety and efficacy of Montelukast formulations. Its characterization aids in understanding potential impacts on therapeutic outcomes and ensures the reliability of drug products containing Montelukast. -
Drug Impurity
Rosuvastatin impurity 21 is a by-product of Rosuvastatin, a potent HMG-CoA reductase inhibitor. This impurity is important for analytical chemistry applications, particularly in the characterization and quality control of pharmaceutical formulations. Its identification and quantification can provide essential insights into the purity and safety of Rosuvastatin-containing products. -
Drug Impurity
Dabigatran impurity 1, also known as Dabigatran Carboxamide, is a known impurity of the anticoagulant Dabigatran. This compound serves as a reference standard in quality control and analytical testing, facilitating the assessment of Dabigatran's purity and stability. Its analysis is essential for ensuring the safety and efficacy of pharmaceutical formulations containing Dabigatran. -
Drug Impurity
Citalopram Impurity 3 Hydrobromide is a known impurity of the selective serotonin reuptake inhibitor Citalopram. This compound is utilized primarily in research settings to assess the purity and quality control of pharmaceutical formulations. Its presence can inform studies on drug stability and regulatory compliance in drug development processes. -
Drug Impurity
rel-trans-Ketoconazole is a drug impurity with relevance in pharmacological research. It serves as a crucial reference standard for the analytical characterization of ketoconazole formulations and related compounds. Its study aids in understanding the stability, safety, and efficacy profiles of ketoconazole derivatives in various biological systems. -
Drug Impurity
Salbutamol impurity 6 is a chemical compound associated with the drug impurity profile of salbutamol. It serves as a reference standard in the analysis and characterization of pharmaceutical formulations, aiding in the assessment of product quality and safety. This impurity can be utilized in research focused on drug metabolism and the development of analytical methods for detecting impurities in pharmaceutical products. -
Drug Intermediate
3'-Fluoro-4'-methylacetanilide serves as a critical drug intermediate in the synthesis of various active pharmaceutical compounds. This compound exhibits properties that facilitate the development of biologically active molecules, making it valuable in medicinal chemistry and pharmaceutical research. Its utility in the preparation of targeted therapeutics underscores its importance in drug discovery and development processes. -
Drug Intermediate
2-Acetamidopyridine serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical ingredients. Its structural properties facilitate the formation of various biologically active compounds, making it valuable in medicinal chemistry and drug development. This reagent is utilized in research applications that explore new therapeutic agents and optimize chemical pathways. -
Drug Impurity
Mesalazine impurity 8 is a known impurity of Mesalazine, a 5-aminosalicylic acid derivative used primarily in the treatment of inflammatory bowel diseases. This compound serves as an important analytical standard for assessing the purity of Mesalazine formulations. Its presence and quantification are essential for ensuring the quality and safety of pharmaceutical products containing Mesalazine. -
Drug Impurity
Benzaldehyde dimethyl acetal serves as a chemical reagent commonly identified as a drug impurity. This compound can impact the purity and safety profile of pharmaceutical formulations, making its analysis critical in drug development and quality control studies. It is utilized in researching stability, interactions, and the degradation pathways of various drug substances. -
Drug Intermediate
(S)-3-Amino-2,2-dimethyl-4-oxoazetidin-1-yl hydrogen sulfate serves as a versatile drug intermediate, facilitating the synthesis of diverse active pharmaceutical compounds. Its unique structural features make it valuable in pharmaceutical research and development, particularly in designing new therapeutic agents. This compound is instrumental in exploring novel drug formulations and enhancing medicinal chemistry efforts. -
Drug Intermediate
(2R,4S)-Ethyl 5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoate acts as a key drug intermediate in the synthesis of diverse bioactive compounds. This reagent is integral for researchers working in medicinal chemistry, facilitating the development of new therapeutic agents. Its structure supports various modifications, enabling the exploration of pharmacological properties and mechanisms of action in drug design. -
Drug Impurity
Camptothecin impurity 1 is a structural variant associated with Camptothecin, an anticancer compound. This impurity may influence the pharmacological properties of Camptothecin and is relevant in the study of drug formulation and stability. Its characterization is crucial for quality control in research applications focused on cancer therapy and drug development. -
Drug Intermediate
(2S)-1-[(tert-Butoxy)carbonyl]-2-methylazetidine-2-carboxylic acid serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical compounds. Its chemical structure enables it to participate in various synthetic pathways, facilitating the development of innovative therapeutic agents. This reagent is essential for research applications focused on drug discovery and development. -
Drug Impurity
Paliperidone impurity 17 is a synthetic impurity associated with paliperidone, an atypical antipsychotic. It serves as a critical reference standard for quality control and method development in pharmaceutical research. This impurity is vital for the evaluation of drug purity and plays an essential role in ensuring the safety and efficacy of paliperidone formulations. -
Drug Intermediate
4,4'-Trimethylenedipyridine is a versatile drug intermediate primarily utilized in the synthesis of diverse active pharmaceutical ingredients. Its chemical structure facilitates the development of compounds with potential therapeutic applications, contributing to advancements in medicinal chemistry. Researchers can employ this intermediate for the design and synthesis of novel drugs targeting various biological mechanisms. -
Drug Intermediate
7-Chloro-6-fluoro-1-(2-isopropyl-4-methyl-3-pyridyl)pyrido[2,3-d]pyrimidine-2,4-dione serves as a crucial drug intermediate in the synthesis of diverse bioactive compounds. Its unique structural features allow for the modification and development of derivatives with therapeutic potential. This compound is particularly valuable in medicinal chemistry research, facilitating investigations into novel drug candidates. -
Drug Intermediate
5-Chlororesorcinol dimethyl ether is a synthetic intermediate primarily used in pharmaceutical synthesis. It serves as a versatile building block for the development of various bioactive compounds. Research applications include the synthesis of potential therapeutic agents and other chemical derivatives in drug discovery processes. -
Drug Intermediate
Pentane-1,3,5-triol serves as a versatile drug intermediate utilized in the synthesis of diverse active pharmaceutical ingredients. This triol structure allows for the modification and development of various compounds, facilitating research in drug development and medicinal chemistry. Its unique reactivity profile makes it essential for creating novel therapeutic agents across different biological applications. -
Drug Intermediate
Ethyl 3,3-dimethyl-4-nitrobutanoate is a key drug intermediate utilized in the synthesis of diverse bioactive compounds. This compound features a nitro group that can facilitate further chemical transformations, making it essential for the development of pharmaceutical agents. Its versatility in organic synthesis lends itself to various research applications, particularly in medicinal chemistry and drug discovery. -
Drug Intermediate
3-((tert-Butoxycarbonyl)amino)-7-fluoro-8-((triisopropylsilyl)ethynyl)naphthalen-1-yl trifluoromethanesulfonate functions primarily as a chemical intermediate in the synthesis of biologically active compounds. Its unique structure facilitates the introduction of diverse functional groups, making it valuable in medicinal chemistry and drug development. This compound is particularly relevant for research applications focused on the creation of novel therapeutic agents. -
Drug Intermediate
tert-Butyl (1H-pyrrol-1-yl)carbamate serves as a versatile drug intermediate in pharmaceutical synthesis. It facilitates the preparation of various active pharmaceutical ingredients, making it valuable in drug development and chemical research. This compound is particularly relevant for studies focused on pyrrole derivatives and their biological applications. -
Drug Intermediate
2-Chloro-1-(4-methoxy-1H-indol-3-yl)ethanone acts as a key intermediate in the synthesis of diverse bioactive compounds. This compound is essential for the development of pharmaceuticals, particularly in the creation of indole-based derivatives. Its structural properties facilitate various synthetic pathways, making it valuable for chemical research and development in medicinal chemistry. -
Drug Intermediate
5-Methoxy-7-azaindole serves as a versatile drug intermediate in the synthesis of a variety of bioactive compounds. Its structural framework allows for modifications that can enhance pharmacological properties. This reagent is primarily utilized in medicinal chemistry for the development of novel therapeutic agents. -
Drug Intermediate
4-(4-Bromobenzyl)morpholine is a drug intermediate utilized in the synthesis of diverse bioactive compounds. This morpholine derivative serves as a versatile building block in medicinal chemistry, facilitating the development of novel pharmaceuticals. Its structural properties enable the modification of biological activity, making it valuable for research applications in drug discovery and development. -
Drug Intermediate
2-Chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxaldehyde serves as a crucial intermediate in the synthesis of diverse bioactive compounds. This compound is essential for drug development, facilitating the incorporation of pyrrolo[2,3-d]pyrimidine moieties into novel therapeutic agents. Its role in medicinal chemistry supports ongoing research aimed at discovering new treatments across various diseases. -
Drug Intermediate
1,3-Dimethylpiperidin-4-one is a versatile drug intermediate utilized in the synthesis of various bioactive compounds. This compound plays a crucial role in the development of pharmaceuticals, particularly in the field of medicinal chemistry. Its structural properties facilitate the formulation of novel therapeutic agents, making it a valuable reagent for research and development in drug discovery. -
Drug Intermediate
(S)-2-(3-Bromophenyl)propanoic acid is a key drug intermediate utilized in the synthesis of diverse active pharmaceutical compounds. Its structure facilitates the development of various therapeutic agents, making it an essential component in medicinal chemistry and drug discovery research. This compound serves as a valuable building block in the production of specialized drugs with potential biological activity. -
Drug Intermediate
4-tert-Butylcalix[4]arene serves as a key drug intermediate in the synthesis of diverse active pharmaceutical compounds. It functions primarily as a ligand and stabilizing agent in various chemical reactions, contributing to the formation of complex architectures. Its versatility in organic synthesis makes it a valuable reagent in pharmaceutical research and development. -
Drug Intermediate
Dimethyl 4-chloropyridine-2,6-dicarboxylate serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical ingredients. This compound is utilized in the development of novel medications, facilitating the construction of complex molecular scaffolds. Its unique structural properties enable the creation of targeted chemical entities for various therapeutic applications. -
Drug Intermediate
(S)-tert-Butyl 6-(hydroxymethyl)-5-azaspiro[2.4]heptane-5-carboxylate serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical compounds. Its unique spirocyclic structure enables its application in the development of novel therapeutics. This intermediate facilitates the exploration of various biological activities and aids in advancing drug discovery research. -
Drug Intermediate
(2-Butyl-5-nitrobenzofuran-3-yl)(4-hydroxyphenyl)methanone serves as a key drug intermediate for the synthesis of diverse pharmacologically active compounds. This compound is notable for its versatile chemical structure, which facilitates the development of various therapeutic agents. It is primarily utilized in drug discovery and development processes, contributing to the advancement of medicinal chemistry research. -
Drug Intermediate
3-(tert-Butoxycarbonyl)-3-azabicyclo[4.1.0]heptane-1-carboxylic acid acts as a valuable drug intermediate in organic synthesis. This compound is utilized in the preparation of various bioactive molecules, facilitating the development of pharmaceuticals in diverse therapeutic areas. Its unique bicyclic structure contributes to the synthesis of targeted compounds with potential biological activity. -
Drug Intermediate
Methyl 3-amino-2-thiophenecarboxylate serves as a key drug intermediate in the synthesis of various biologically active compounds. This compound facilitates the formation of novel pharmaceuticals and research chemicals through its reactive amino and carboxyl functional groups. Its versatility makes it valuable in medicinal chemistry and compound development. -
Drug Intermediate
4-Chloro-2,5-difluorophenylboronic acid pinacol ester is a versatile drug intermediate commonly utilized in synthetic chemistry. This compound serves as a key building block for the construction of a variety of biologically active molecules, facilitating the design and development of therapeutic agents. Its boronic acid functionality allows for diverse coupling reactions, making it essential in medicinal chemistry research. -
Drug Intermediate
Benzyl (4-aminobicyclo[2.1.1]hexan-1-yl)carbamate hydrochloride primarily serves as a drug intermediate, facilitating the synthesis of diverse active pharmaceutical compounds. This reagent is important in medicinal chemistry applications, enabling researchers to explore various therapeutic targets and develop novel drug candidates. Its unique bicyclic structure enhances its utility in chemical reactions and compound modifications, making it a valuable asset in pharmaceutical research and development. -
Drug Intermediate
1H-Pyrrolo[2,3-b]pyridine 7-oxide serves as a versatile drug intermediate vital for the synthesis of diverse active pharmaceutical compounds. This heterocyclic compound facilitates the development of novel therapeutic agents and is instrumental in chemical research aimed at enhancing drug efficacy and safety profiles. Its unique structure makes it a valuable building block in medicinal chemistry. -
Drug Intermediate
Benzyl methyl(2-(methylamino)ethyl)carbamate serves as a key drug intermediate in the synthesis of numerous bioactive compounds. Its molecular structure allows for versatility in chemical transformations, facilitating the development of new pharmaceuticals. This reagent is widely utilized in drug formulation and medicinal chemistry research applications. -
Drug Intermediate
3-Trichlorovinylaniline hydrochloride serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical compounds. Its unique structure facilitates the development of targeted therapeutic agents, contributing to advancements in medicinal chemistry. This reagent is particularly valuable in research applications focused on the design and optimization of novel chemical entities. -
Drug Intermediate
2-(2-Pyridin-2-ylethyl)aniline is a versatile drug intermediate utilized in the synthesis of diverse active pharmaceutical ingredients. Its primary function involves facilitating the incorporation of pyridine moieties into various chemical frameworks, thereby enhancing biological activity. This compound is significant in medicinal chemistry research, aiding the development of therapeutics with novel properties. -
Drug Intermediate
tert-Butyl 2,2-dimethyl-5-oxopiperidine-1-carboxylate primarily serves as a versatile drug intermediate in organic synthesis. This compound is valuable for the construction of various bioactive molecules, facilitating the development of pharmaceuticals across multiple therapeutic areas. It is particularly useful in medicinal chemistry for the design and production of novel agents. -
Drug Intermediate
4-Hydroxy-5-methoxy-2-nitrobenzoic acid serves as a key intermediate in the synthesis of various active pharmaceutical ingredients. This compound is widely utilized in the development of therapeutic agents, facilitating the creation of diverse chemical entities in drug discovery and development. Its structural attributes enable modifications that enhance pharmacological properties, making it an essential reagent for researchers focused on medicinal chemistry. -
Drug Intermediate
(S)-Ethyl 5-((benzyloxy)imino)-2-((tert-butoxycarbonyl)amino)-6-chlorohexanoate acts as a versatile drug intermediate in organic synthesis. This compound is crucial for the development of various bioactive molecules, facilitating the assembly of complex pharmaceuticals. Its structural properties enable targeted modifications, making it an essential reagent for research in medicinal chemistry and drug development. -
Drug Intermediate
(2-Butyl-5-nitrobenzofuran-3-yl)(4-methoxyphenyl)methanone serves as a versatile drug intermediate in organic synthesis. This compound plays a key role in the production of various bioactive molecules, facilitating the development of pharmaceutical agents. Its structural attributes make it suitable for research applications focused on drug discovery and development. -
Drug Intermediate
Methyl 4-amino-2,6-dimethoxybenzoate serves as a versatile drug intermediate, facilitating the synthesis of a range of active pharmaceutical compounds. This compound is valuable in medicinal chemistry research, contributing to the development of novel therapeutic agents. Its structure allows for various modifications, expanding its utility in the creation of targeted drug classes. -
Drug Intermediate
4-(2-(Piperidin-1-yl)ethoxy)benzaldehyde serves as a valuable drug intermediate in the synthesis of various bioactive compounds. Its versatile structure allows for the production of complex molecules used in pharmaceutical research. This compound is particularly relevant in the development of potential therapeutics, facilitating studies in medicinal chemistry and drug design. -
Drug Intermediate
2-tert-Butoxyethylamine hydrochloride serves as a crucial drug intermediate in the synthesis of various active pharmaceutical ingredients. Its structure facilitates the development of compounds with potential therapeutic benefits, making it valuable for medicinal chemistry research. This reagent is essential for formulating novel drug candidates and optimizing their efficacy. -
Drug Intermediate
1-Bromo-4-dimethylphosphoryl-benzene serves as a key drug intermediate in the synthesis of diverse bioactive compounds. Its unique phosphonyl moiety enhances reactivity and facilitates the formation of various derivatives relevant to pharmaceutical research. This compound is essential for studies involving the development of novel therapeutic agents.
